NEW YORK – Tilray Brands, Inc. (NASDAQ:TLRY), a company specializing in medicinal chemicals and botanical products currently trading near its 52-week low, has reached a settlement agreement regarding ...

Medical announced the expansion of its medical cannabis extract portfolio in Germany. Tilray’s new medical cannabis offerings in ...

Tilray's major story during the year was its concentrated attempts to diversify away from marijuana, which is hardly a ringing endorsement of its efforts with the core products. The company spent ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Tilray Brands, Inc. (“Tilray” or “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, today ...

Shares of Tilray Brands Inc. TLRY advanced 1.05% to $0.95 Wednesday, on what proved to be an all-around mixed trading session ...

This was the stock's fourth consecutive day of losses.

One of the top cannabis stocks in the industry is Tilray Brands (TLRY-5.66%), and ... respect to expansion or offering too many types of products. While Tilray has been eager to become a top ...

Tilray's major story during the year was its concentrated attempts to diversify away from marijuana, which is hardly a ringing endorsement of its efforts with the core products. Bursting with ...

The Company's extensive cultivation capacity is designed to provide a consistent and reliable supply of premium cannabis products to over 20 legal cannabis markets worldwide. Tilray's commitment ...